p-tau 181
Selected indexed studies
- Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis. (Int J Mol Sci, 2024) [PMID:39684623]
- Aβ(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease. (J Alzheimers Dis, 2025) [PMID:40267266]
- Phosphorylated tau 181 (p-tau(181)) as an innovative, fast and robust biomarker for cerebrospinal fluid leaks. (J Neurol, 2024) [PMID:39162804]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis. (2025) pubmed
- Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis. (2024) pubmed
- Aβ(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease. (2025) pubmed
- Phosphorylated tau 181 (p-tau(181)) as an innovative, fast and robust biomarker for cerebrospinal fluid leaks. (2024) pubmed
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease. (2020) pubmed
- An accurate fully automated panel of plasma biomarkers for Alzheimer's disease. (2023) pubmed
- Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease. (2023) pubmed
- Plasma biomarkers predict Alzheimer's disease before clinical onset in Chinese cohorts. (2023) pubmed
- Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study. (2021) pubmed
- CSF Aβ(1-42,) but not p-Tau(181,) differentiates aMCI from SCI. (2018) pubmed